<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02404454</url>
  </required_header>
  <id_info>
    <org_study_id>MulticentricMetroplasty</org_study_id>
    <nct_id>NCT02404454</nct_id>
  </id_info>
  <brief_title>Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Università degli Studi di Sassari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale di Cagliari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale di Olbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale di Oristano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cagliari</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The septate uterus is the most common structural uterine anomaly. It results from failure of
      the partition between the two fused Müllerian ducts to resorb;it is associated with the
      highest incidence of reproductive failure and with first- and second-trimester pregnancy loss
      and infertility.

      Hysteroscopic division of the uterine septum is performed using microscissors,
      electrosurgery, or laser. Several studies shown significant improvement in pregnancy outcome
      after hysteroscopic metroplasty.

      Purpose of this study is to verify the effectiveness of 5 ml, instead of 10 ml, of
      autocross-linked hyaluronic acid gel in the prevention of the formation of intrauterine
      adhesions, through second look office hysteroscopy after three months.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Formation of intrauterine adhesions</measure>
    <time_frame>baseline (operative isteroscopy and three months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Intrauterine Adhesions</condition>
  <condition>Septate Uterus</condition>
  <arm_group>
    <arm_group_label>hysteroscopic metroplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>women undergoing hysteroscopic metroplasty for uterine septum resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysteroscopic metroplasty</intervention_name>
    <arm_group_label>hysteroscopic metroplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autocross-linked acid hyaluronic gel</intervention_name>
    <description>Patients received adhesion barrier with 5 ml of autocross-linked acid hyaluronic gel</description>
    <arm_group_label>hysteroscopic metroplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Office second look hysteroscopy</intervention_name>
    <description>Second-look hysteroscopy after three months</description>
    <arm_group_label>hysteroscopic metroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  uterine septum

          -  history of ≥1 miscarriage or infertility;

          -  desire to have children in the future

        Exclusion Criteria:

          -  pregnancy;

          -  menopause;

          -  precancerous state or malignancy of the reproductive organs;

          -  benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)

          -  lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on
             ultrasonography;

          -  withdrawal of patient consent;

          -  rare complex uterine congenital anomalies without an ASRM classification such as
             uterine septum with double cervix ;

          -  presence of external intercornual cleft;

          -  incomplete (internal fundal indentation 10 mm) or non-standardized septum resection
             (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the
             fundus), confirmed intraoperatively

          -  excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed
             intraoperatively)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2015</study_first_posted>
  <last_update_submitted>March 8, 2016</last_update_submitted>
  <last_update_submitted_qc>March 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cagliari</investigator_affiliation>
    <investigator_full_name>Stefano Angioni</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

